image-guided-surgery
(6)
NDR Medical Technology
NDR Medical Technology is a Singapore-based deep-tech company building AI-empowered interventional robotics for minimally invasive, image-guided surgery. Its Automated Needle Targeting (ANT) platform combines hardware and software to plan and align percutaneous needle placement with roughly ±1mm accuracy using a hospital's existing imaging equipment. Its flagship ANT-X robot received U.S. FDA 510(k) clearance in 2023 as the first automated device to aid kidney access for percutaneous nephrolithotomy, while ANT-C brings AI CT-based lesion targeting to procedures across the lung, liver, kidney and spine.
AiM Medical Robotics
AiM Medical Robotics is a Worcester, Massachusetts medical device company building a portable, MRI-compatible surgical robot that lets neurosurgeons operate under continuous, real-time MRI guidance. Spun out of Gregory Fischer's Automation and Interventional Medicine (AIM) lab at Worcester Polytechnic Institute, the platform aims to make procedures such as deep brain stimulation lead placement, biopsy, tumor ablation and targeted drug delivery faster, more precise and less variable - reducing procedure time by up to 50% and expanding access to advanced neurosurgical care.
CairnSurgical, Inc.
CairnSurgical is a clinical-stage medical device company in Lebanon, New Hampshire, building patient-specific surgical guidance for breast cancer lumpectomy. Its Breast Cancer Locator (BCL) System pairs a 3D-printed, bra-like form molded to each patient's anatomy with an interactive 3D Visualizer derived from supine MRI, giving surgeons a precise blueprint of a tumor's size, shape, depth and edges. The goal is to cut the 20 to 25 percent re-excision rate in breast-conserving surgery toward zero. Spun out of Dartmouth College and Dartmouth-Hitchcock Medical Center in 2015, the company reported 94 percent margin-negative resections in a European study and filed for FDA De Novo clearance in 2026.
Dave Danielsen
Dave Danielsen is the CEO of CairnSurgical, a clinical-stage medical device company in Lebanon, New Hampshire, that spun out of Dartmouth in 2015. He leads development of the Breast Cancer Locator System, a patient-specific, 3D-printed surgical guide paired with visualization software that helps surgeons see a tumor's size, shape, and location before a lumpectomy and remove it with cleaner margins. A West Point graduate with a Tuck School MBA, Danielsen has spent his career running commercial-stage health and diagnostics companies, and is now steering CairnSurgical through its U.S. pivotal trial, FDA submission, and early commercial launch in Europe.
Gregory Fischer
Gregory Fischer is the co-founder and CEO of AiM Medical Robotics, a Worcester, Massachusetts company building a portable, MRI-compatible surgical robot for neurosurgery. A robotics engineer with a PhD from Johns Hopkins, Fischer spent nearly two decades as a professor at Worcester Polytechnic Institute, where he directed the Automation and Interventional Medicine (AIM) Robotics Lab and founded the PracticePoint medtech R&D center. He turned his NIH-funded research into a company aiming to bring real-time image guidance and submillimeter robotic precision into the operating room, with a first-in-human clinical study on the horizon after a $8.1 million Series A in 2025.
Illuminant Surgical
Illuminant Surgical is a Culver City / Los Angeles medical device startup building Skylight, a real-time anatomical projection system that displays a patient's internal imaging directly onto their skin during surgery. Using AI, computer vision and dynamic projection mapping - technology borrowed in part from entertainment-industry projection artists - the company aims to give surgeons a kind of 'x-ray vision' for spine surgery, cancer biopsies and other image-guided procedures without forcing them to look away from the operating field.